MedPath

THERACLION

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

18

Active:1
Completed:12

Trial Phases

3 Phases

Early Phase 1:1
Phase 1:1
Not Applicable:16

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (18 trials with phase data)• Click on a phase to view related trials

Not Applicable
16 (88.9%)
Early Phase 1
1 (5.6%)
Phase 1
1 (5.6%)

Extracorporeal Flow Abolition in Relation With Primary Insufficiency of Great Saphenous Veins (GSV) Using High Intensity Focused Ultrasound (HIFU) Generated by Sonovein: A Multi Center Prospective Pivotal Study

Not Applicable
Completed
Conditions
Chronic Venous Insufficiency
First Posted Date
2023-07-03
Last Posted Date
2025-06-19
Lead Sponsor
Theraclion
Target Recruit Count
70
Registration Number
NCT05926830
Locations
🇺🇸

Englewood Health, Englewood, New Jersey, United States

🇺🇸

Northwell Health, Lake Success, New York, United States

🇦🇹

Praxis für Phlebologie, Melk, Austria

and more 1 locations

Treatment of Insufficient Superficial and Perforatring Veins of the Lower Limb Using HIFU

Not Applicable
Completed
Conditions
Varicose Ulcer
Varicose Veins
Veins Diseases
First Posted Date
2020-02-21
Last Posted Date
2020-10-06
Lead Sponsor
Theraclion
Target Recruit Count
22
Registration Number
NCT04280679
Locations
🇦🇹

Karl Landsteiner Institut für funktionelle Phlebochirurgie, Melk, Austria

HIFU Treatment of Benign Thyroid Nodules

Not Applicable
Not yet recruiting
Conditions
Thyroid Nodule (Benign)
First Posted Date
2020-01-18
Last Posted Date
2024-04-11
Lead Sponsor
Theraclion
Target Recruit Count
240
Registration Number
NCT04233398

Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)

Not Applicable
Terminated
Conditions
Breast Fibroadenoma
First Posted Date
2018-11-15
Last Posted Date
2020-03-16
Lead Sponsor
Theraclion
Target Recruit Count
2
Registration Number
NCT03742401
Locations
🇫🇷

Hopital Européen, Marseille, France

🇫🇷

CHU de Montpellier, Montpellier, France

🇫🇷

Polyclinique Majorelle, Nancy, France

and more 9 locations

Treatment of Insufficient Superficial and Perforating Veins of the Lower Limb Using HIFU

Not Applicable
Completed
Conditions
Veins Diseases
Varicose Ulcer
Vein, Varicose
First Posted Date
2017-10-09
Last Posted Date
2018-11-29
Lead Sponsor
Theraclion
Target Recruit Count
50
Registration Number
NCT03304834
Locations
🇦🇹

Karl Landsteiner Institut für funktionelle Phlebochirurgie, Melk, Austria

  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

News

Theraclion's SONOVEIN® SpeedPulse Innovation Promises Faster Varicose Vein Treatment

Theraclion has initiated clinical trials for SONOVEIN® 'SpeedPulse', a new feature that significantly reduces treatment time for varicose veins using high-intensity focused ultrasound technology.

Focused Ultrasound Trial Aims to Boost Immunotherapy Response in Melanoma

UVA Health is conducting a clinical trial to assess focused ultrasound's ability to enhance immunotherapy outcomes in melanoma patients undergoing surgery.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.